Biolargo Inc (BLGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,763 | 560 | 97 | 227 | 155 |
| Receivables | 41 | 38 | 8 | 7 | 6 |
| Inventories | 37 | 13 | 15 | 21 | 26 |
| TOTAL | $1,891 | $667 | $164 | $300 | $231 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 19 | 101 | 100 | 83 | 30 |
| TOTAL | $19 | $101 | $100 | $83 | $30 |
| Total Assets | $1,910 | $768 | $264 | $383 | $261 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 325 | 276 | 444 | 512 | 495 |
| Other current liabilities | 135 | 125 | 100 | 150 | 100 |
| TOTAL | $460 | $401 | $710 | $791 | $653 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 4 | N/A |
| Other Non-Current Liabilities | 316 | 112 | 45 | 11 | -31 |
| TOTAL | $309 | $110 | $40 | $6 | $N/A |
| Total Liabilities | $769 | $511 | $749 | $797 | $653 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 86,272 | 85,787 | 84,469 | 83,322 | 83,000 |
| Common Shares | 57 | 57 | 56 | 56 | 55 |
| Retained earnings | -84,076 | -82,824 | -81,004 | -79,794 | -79,020 |
| Other shareholders' equity | 749 | 47 | 49 | 43 | 61 |
| TOTAL | $1,141 | $257 | $-485 | $-414 | $-392 |
| Total Liabilities And Equity | $1,910 | $768 | $264 | $383 | $261 |